Non-Billable / Non-Specific Code
ICD-10-CM N40 is the diagnosis code for Benign prostatic hyperplasia. This code falls under the section "Diseases of male genital organs" within Chapter 14 â Diseases of the genitourinary system (N00-N99). It is a non-billable/non-specific ICD-10-CM code that should not be used for reimbursement. A more specific sub-code is required for billing. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
The following conditions should never be coded at the same time as N40. They are mutually exclusive:
The following conditions are not included in N40. If the patient has both, code each condition separately:
Understanding where N40 sits in the ICD-10-CM classification helps ensure proper coding:
No, N40 is a non-billable/non-specific code. You should use a more specific sub-code for billing and reimbursement.
N40 is the ICD-10-CM diagnosis code for "Benign prostatic hyperplasia". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
N40 is located in Section N40-N53 â "Diseases of male genital organs" within Chapter 14 of the ICD-10-CM Tabular List.
N40 has 4 sub-code(s) that provide more specific detail: N40.0, N40.1, N40.2, N40.3.
Use N40 when the patients documented diagnosis matches "Benign prostatic hyperplasia" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Benign prostatic hyperplasia is N40.
No, N40 is non-billable. Use a more specific sub-code for primary diagnosis billing.
N40 is in Chapter 14 of the ICD-10-CM Tabular List.
Type 1 Excludes for N40 include: benign neoplasms of prostate (adenoma, benign) (fibroadenoma) (fibroma) (myoma) (D29.1).
Yes, N40 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.